期刊文献+

VEGF在类风湿关节炎滑液中的表达及上调MMP-2活性的研究 被引量:7

Expression of vascular endothelial cell growth factor and its upregulation of matrix metalloproteinase-2 activation in synovial fluid of patients with rheumatoid arthritis
原文传递
导出
摘要 目的探讨血管内皮生长因子(VEGF)在类风湿关节炎(RA)患者关节滑液中的表达及其上调基质金属蛋白酶-2(MMP-2)活性在RA关节损伤机制中的意义。方法采用免疫印迹法、酶联免疫吸附试验、明胶酶谱电泳分析法及侵袭小室法,观察RA患者组及对照组关节滑液单个核细胞中VEGF及受体KDR的表达,单个核细胞上清液中VEGF的水平,VEGF与KDR阳性的单个核细胞体外共培养前后上清中MMP-2的活性及细胞侵袭力的变化。结果VEGF及KDR在滑液单个核细胞高表达;共培养后MMP-2的活性及细胞的侵袭力明显增强。结论VEGF与受体KDR结合促使RA滑液单个核细胞MMP-2活性上调及细胞侵袭力的增强,促进受损关节软骨及骨的降解破坏。 Objective To investigate the expression of vascular endothelial cell growth factor (VEGF) and its upregulation of matrix metalloproteinase-2 (MMP-2) activation in synovial fluid of patients with rheumatoid arthritis (RA) as well as its role in the pathogeneses of RA. Mathods Expression of VEGF and receptor KDR in mononuclear cell (MNC) of synovial fluid of RA patients and controls were determined by Western blot; VEGF levels of supernantants from MNC was determined by ELISA; supernantants from KDR^+ MNC of synovial fluid of RA patients collected after incubation in serum-free medium with or without VEGF, their activity of MMP-2 was measured by gelatinolytic zymography; Boyden chamher-matrigel in vitro invasion assay was used to detect the invasive capacity in vitro in KDR^+ MNC of synovial fluid of RA patients incubated with or without VEGF. Results The expressions of VEGF/KDR in MNC of synovial fluid of RA patients were significantly higher than those of controls; the MMP-2 activity and invasive ability of co-cultured KDR^+ MNC with VEGF was higher than those of without VEGF. Conclusion VEGF upregulates MMP-2 activation and promotes invasion of MNC of synovial fluid of RA patients by interacting with receptor KDR, indicating that VEGF plays an important role in RA pathology.
出处 《中华风湿病学杂志》 CAS CSCD 2006年第8期495-497,共3页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 内皮生长因子 基质金属蛋白酶 Arthritis, rheumatoid Endothelial growth factor Matrix metalloproteinases
  • 相关文献

参考文献11

  • 1Kasama T, Kobayashi K, Yajima N, et al. Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis. Clin Exp Immunol, 2000, 121: 533-538.
  • 2Sone H, Sakauchi M, Takahashi A, et al. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci,2001, 69: 1861-1869.
  • 3Jain A, Nanchahal J, Troeberg L, et al. Production of cytokines,vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.Arthritis Rheum, 2001, 44: 1754-1760.
  • 4Paleolog EM. Angiogenesis: a critical process in the pathogenesis of RA; a role for VEGF. Br J Rheumatol, 1996, 35: 917-919.
  • 5Bottomly MJ, Webb NJ, Watson CJ, et al. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secret vascular endothelial growth factor (VEGF): specific up-regulation by tumor necrosis factor-alpha (TNF-α) in synovial fluid. Clin Exp Immunol, 1999, 117: 171-176.
  • 6Zhu P, Ding J, Zhou J, et al. Expression of CD147 on monocytes /macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.Arthritis Res Ther, 2005, 7: R1023-1033.
  • 7Konttinen YT, Li TF, Mandelin J, et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum, 2000, 43: 275-280.
  • 8Tomita T, Nakase T, Kaneko M, et al. Expression of extracellular matrix metalloproteinase inducer and enhancement of production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum, 2002, 46:373-378.
  • 9Makowski GS, Ramsby ML. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chem Acta, 2003, 329: 77-81.
  • 10Giannelli G, Erriquez R, Iannone F, et al. MMP-2, MMP-9,TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumatol, 2004, 22: 335-338.

同被引文献93

引证文献7

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部